This article was originally published in The Gray Sheet
FDA administrative law judge rules July 6 that Colorado-based TMJ Implants and two executives are liable for civil money penalties of up to $630,000 for not filing 17 adverse event reports. The events were documented in a February 2004 warning letter to the firm, which makes temporomandibular joint prostheses. The company maintains its internal assessment showed the events did not meet the reporting threshold of causing or contributing to a serious injury and appealed the matter to the FDA commissioner before the agency entered a complaint with the administrative court in July 2005 (1"The Gray Sheet" Jan. 1, 2007, p. 4). The case has resulted in pressure on FDA from House Republicans questioning the fairness of the warning letter appeals process based on TMJ's assertions that its plea to the commissioner was short circuited (2"The Gray Sheet" May 7, 2007, p. 7)...
You may also be interested in...
Senior House Republicans are challenging FDA on the fairness of its warning letter appeals process in response to an agency dispute with dental device manufacturer TMJ Implants
FDA and Colorado-based TMJ Implants will seek resolution to an almost three-year-old dispute over the interpretation of medical device adverse event reporting regulations before an administrative law judge in April
Diagnostics company Bodysphere had to retract an announcement that it had received an emergency use authorization from the US FDA for a COVID-19 serologic test. See why Bethany Hills, an attorney with law firm Morrison & Foerster, says this may be a cautionary tale for other manufacturers.